Viewing data from:

LITHIUM CARBONATE

ANDA

LITHIUM CARBONATE | A076832 | HIKMA PHARMACEUTICALS USA INC

1 strength0 unique patents0 unique exclusivities

Reference Listed Drug: LITHOBID(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 3 NDCs

Highest NADAC/Unit

$0.2012

per ea

Lowest NADAC/Unit

$0.2012

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
68084064001LITHIUM CARBONATE ER 300 MG TB	$0.2012	EA	Generic	—	2026-06-17
00054002125LITHIUM CARBONATE ER 300 MG TB	$0.2012	EA	Generic	—	2026-06-17
00054002129LITHIUM CARBONATE ER 300 MG TB	$0.2012	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 3 NDCs (3 FSS)

Lowest Price

$10.50

Highest Price

$149.50

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
72789-0171-01LITHIUM CARBONATE 300MG TAB,SA	$31.20	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
72789-0171-30LITHIUM CARBONATE 300MG TAB,SA	$10.50	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026
72789-0171-82LITHIUM CARBONATE 300MG TAB,SA	$149.50	FSS	PD-Rx Pharmaceuticals, Inc.	05/31/2026

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain11 active DMFs7 inactive

11 active API suppliers hold Drug Master Files for this ingredient.

LIVENT USA CORPLITHIUM CARBONATE

DMF 12411968

ALBEMARLE CORPLITHIUM CARBONATE USP

DMF 42421981

LEK PHARMACEUTICALS DDLITHIUM CARBONATE ACTIVE SUBSTANCE

DMF 156772001

SUN PHARMACEUTICAL INDUSTRIES LTDLITHIUM CARBONATE USP

DMF 208242007

EUTICALS SPALITHIUM CARBONATE PHARMA GRADE

DMF 231752009

ALIVUS LIFE SCIENCES LTDLITHIUM CARBONATE USP

DMF 336292019

HONOUR LAB LTDLITHIUM CARBONATE

DMF 392432023

UNIQUE CHEMICALS (A DIV OF J B CHEMICALS AND PHARMACEUTICALS LTD)LITHIUM CARBONATE USP

DMF 405102025

EMNAR PHARMA PRIVATE LTDLITHIUM CARBONATE

DMF 407822024

JIANGSU NHWA PHARMACEUTICAL CO LTDLITHIUM CARBONATE USP

DMF 430932025

MAITHRI DRUGS PRIVATE LTDLITHIUM CARBONATE USP

DMF 437402026

LYNE LABORATORIES INCInactiveLITHIUM CARBONATE TABLETS

DMF 11901968

METALLGESELLSCHAFT AGInactiveLITHIUM CARBONATE

DMF 36271979

FOOTE MINERAL COInactiveLITHIUM CARBONATE, USP

DMF 37731980

ANI PHARMACEUTICALS INCInactiveLITHIUM CARBONATE PILOT PROCESS

DMF 37781980

RUETGERS NEASE CHEMICAL CO INCInactiveLITHIUM CARBONATE, BULK

DMF 37921980

LEK PHARMACEUTICAL AND CHEMICAL CO DDInactiveLITHIUM CARBONATE

DMF 42931981

LIMTECH CARBONATE INCInactiveLITHIUM CARBONATE, USP GRADE

DMF 191582006

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 300MG

0 patents0 exclusivities▴

TABLET, EXTENDED RELEASE;ORAL | Approved: Oct 28, 2004

No patent or exclusivity listings for this strength.